Stanford Women's Cancer Center is a clinical research site located in Stanford, California, United States 94305.
Crixeo Clinical Trials Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.
Stanford Women's Cancer Center has participated in 11 clinical trials with 2 currently active.
Therapeutic areas: Advanced Estrogen Receptor Positive HER2- Breast Cancer, Early Breast Cancer, Breast Neoplasms.
Sponsors: Gilead Sciences, Pfizer, AstraZeneca.
Trust Score: 75/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Stanford Women's Cancer Center has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Stanford Women's Cancer Center has 11 clinical trials on record, with 2 currently active. Their work covers Advanced Estrogen Receptor Positive HER2- Breast Cancer, Early Breast Cancer, Breast Neoplasms.
Stanford Women's Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.